BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26769756)

  • 1. Hepatitis B immune reconstitution syndrome in a patient with HIV infection.
    John MA; Gosnell BI; Manzini TC; Ramdial P; Moosa MS
    Int J STD AIDS; 2016 Oct; 27(12):1126-1129. PubMed ID: 26769756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
    Puoti M; Cozzi-Lepri A; Ancarani F; Bruno R; Ambu S; Ferraro T; Tundo P; Santantonio T; Toti M; Bonasso M; d'Arminio Monforte A; ;
    Antivir Ther; 2004 Oct; 9(5):811-7. PubMed ID: 15535419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Kouanfack C; Aghokeng AF; Mondain AM; Bourgeois A; Kenfack A; Mpoudi-Ngolé E; Ducos J; Delaporte E; Laurent C
    Antivir Ther; 2012; 17(2):321-6. PubMed ID: 22290198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
    Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Drake A; Mijch A; Sasadeusz J
    Clin Infect Dis; 2004 Jul; 39(1):129-32. PubMed ID: 15206064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].
    Rey D; Fritsch S; Schmitt C; Partisani M; Kempf-Durepaire G; Nicolle M; Krantz V; De Mautort E; Stoll-Keller F; Lang JM
    Gastroenterol Clin Biol; 2000 Jan; 24(1):125-7. PubMed ID: 10679599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.
    Pirillo MF; Scarcella P; Andreotti M; Jere H; Buonomo E; Sagno JB; Amici R; Mancini MG; Leone P; Ceffa S; Mancinelli S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Viral Hepat; 2015 Mar; 22(3):289-96. PubMed ID: 25174900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary infection with a lamivudine-resistant hepatitis B virus.
    Thibault V; Aubron-Olivier C; Agut H; Katlama C
    AIDS; 2002 Jan; 16(1):131-3. PubMed ID: 11741175
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment.
    Aghasadeghi MR; Bahramali G; Sadat SM; Farahani A; Mohraz M; Davar Siadat S; Mostafavi E; Memarnejadian A; Ardestani MS; Vahabpour R; Saraji AA; Delbaz SA
    Curr HIV Res; 2011 Jun; 9(4):263-9. PubMed ID: 21671883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.
    Tajima K; Kohno K; Shiono Y; Suzuki I; Kato Y; Hiroshima Y; Yamamoto M; Ohtake H; Iwaba A; Yamakawa M; Kato T
    Int J Clin Exp Pathol; 2013; 6(3):536-42. PubMed ID: 23411777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL
    AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
    Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
    J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome.
    Zaltron S; Cambianica A; Di Gregorio M; Colangelo C; Storti S; Tiecco G; Castelli F; Quiros-Roldan E
    Front Cell Infect Microbiol; 2023; 13():1143346. PubMed ID: 37124041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
    de Vries-Sluijs TE; van der Eijk AA; Hansen BE; Osterhaus AD; de Man RA; van der Ende ME
    J Clin Virol; 2006 May; 36(1):60-3. PubMed ID: 16418013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of hepatitis B and C viruses in patients infected with HIV.
    Rong-Rong Y; Xi-En G; Shi-Cheng G; Yong-Xi Z
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):505-6. PubMed ID: 18614932
    [No Abstract]   [Full Text] [Related]  

  • 20. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
    Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
    J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.